ArticlePloS one2012

CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.

Xuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.